EGFR and cancer: It may be used as the likely treatment for deterring EGFR and MET receptor‐expressed cancer cells (MCF‐7 human breast cancer), HepG2 (liver cancer), and NCIH 460 (non‐small cell lung cancer) (Ilangovan et al., 2023).